Tapewire

Nasdaq · USD

CRTO

Criteo S.A.

Export transactions ↓
Tapewire entity
291
SEC CIK
0001576427
Parsed reports
363

Last 12 months

Inside the activity.

4 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202533
Dec 202501
Jan 202600
Feb 202604
Mar 202614
Apr 202600
May 202604
Jun 202602
Jul 202600
Aug 202608
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 27, 2016 Filed Oct 28, 2016 16:17 UTC GrantNon-employee Warrant (right to buy) · Derivative 13,185 $0.00 Strike: $36.92 $0.00
Disclosure

SEC source: 0001576427-16-000382 · wf-form4_147768584935680.xml · derivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,185

Underlying: Ordinary Shares · 13,185 shares

Expires 2026-10-27

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866).

F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
October 27, 2016 Filed Oct 28, 2016 20:12 UTC
EVAN DANA LDirector
GrantNon-employee Warrant (right to buy) · Derivative 13,185 $0.00 Strike: $36.92 $0.00
Disclosure

SEC source: 0001576427-16-000378 · wf-form4_147768550658129.xml · derivative · entry 1

EVAN DANA L · CIK 0001204818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,185

Underlying: Ordinary Shares · 13,185 shares

Expires 2026-10-27

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866)

F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
October 27, 2016 Filed Oct 28, 2016 16:14 UTC
WARNER JAMESDirector
GrantNon-employee Warrant (right to buy) · Derivative 13,185 $0.00 Strike: $36.92 $0.00
Disclosure

SEC source: 0001576427-16-000380 · wf-form4_147768565756566.xml · derivative · entry 1

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,185

Underlying: Ordinary Shares · 13,185 shares

Expires 2026-10-27

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866)

F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
October 04, 2016 Filed Oct 5, 2016 20:19 UTC
Rudelle Jean-BaptisteDirector · Executive Chairman
SaleOrdinary Shares 10,873 $36.09 $392,406.57
Disclosure

SEC source: 0001576427-16-000375 · wf-form4_147569873108907.xml · nonDerivative · entry 2

Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,795,958

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.67 to $36.55, inclusive.

Read SEC document
October 03, 2016 Filed Oct 5, 2016 20:19 UTC
Rudelle Jean-BaptisteDirector · Executive Chairman
SaleOrdinary Shares 49,127 $35.78 $1,757,764.06
Disclosure

SEC source: 0001576427-16-000375 · wf-form4_147569873108907.xml · nonDerivative · entry 1

Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,806,831

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.14 to $36.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (4) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.